Plethora Solutions shares plunge on urgent financing talks

5th Feb 2013 11:07

Plethora Solutions is in urgent discussions with third parties to finance the company's working capital purposes. Shares in the pharmaceutical company plummeted 55.00% to 2.25p at 11:18 following Tuesday's announcement. The company said it remained focused on the development of SD502, a drug for treating premature ejaculation.However, the group is undertaking strategic review of its commitment to The Urology Company.The Urology Company works with partner companies across the globe in providing products for the treatment of urological disorders to healthcare professionals and UK patients. RD